supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Catechin
drug:
Aldesleukin
Research Papers that Mention the Interaction
“Taken together, these results demonstrate that (+)-catechin inhibits tumour-specific angiogenesis by regulating the production of pro- and anti-angiogenic factors such as pro-inflammatory cytokines, nitric oxide, VEGF, IL-2 and TIMP-1.”
“3) Compared with E, the activity of IL-2 in group B and C decreased significantly (P < 0.01).”
“Cross-linking CD3 + HLA-A,B C caused a rapid and prolonged increase in [Ca2+]i and synergistically increased IL-2 production and proliferation of all clones.”
Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.“ Co-stimulation with poly I: C and LL-37 enhanced pro-inflammatory IL-6 and MCP-1 transcripts several fold compared to treatment with poly I:C or LL-37 alone.”
“Synergistic induction after co-stimulation with IL-17A and polyI: C was observed from 2 to 24 hours after stimulation.”
“05 ); The levels of interleukin 2 in the 3 treated group ( Group B, C , and D) were significantly lower than those of Group A ( P < 0.”
[Therapeutic effect of fuzheng yangying oral solution on immune-induced aplastic anemia mice].“Poly I C significantly promoted more IL-2 and IFN γ production as well as higher lytic activity of CAR-T cells.”
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback